Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Drug Discovery 84
Oncology Drugs 79
Optical Disorders Drugs 78
Optical 75
Immune Disorders Drugs 67
Cardiovascular Drugs 46
Biopharmaceuticals 40
Dermatological Drugs 38
Musculoskeletal Disorders Drugs 38
Genomics 30
Biotechnology 28
Clinical Trials 28
Endocrine and Metabolic Disorders Drugs 27
Pharmaceuticals 22
Skin Cancer Drugs 21
Infectious Diseases Drugs 19
Allergy and Immunology 17
Central Nervous System Drugs 17
Respiratory Drugs 17
Gastrointestinal Drugs 14
Allergy Drugs 14
Infusions and Injectables 13
Drugs by Therapeutic Area 11
Lung Cancer Drugs 11
Hematological Drugs 11
Leukemia Drugs 9
Dermatology 8
Oncology 8
Asthma Drugs 8
Pharmaceutical Manufacturing 8
Analgesics 7
Diagnostics 7
Needles and Syringes 7
Biosimilars and Biosuperiors 6
Therapeutic Area 5
Prostate Cancer Drugs 5
Lymphoma Drugs 5
Enzymes 5
Company Reports 4
Ovarian Cancer Drugs 4
Cardiovascular Devices 4
Transdermal and Transmucosal Drug Delivery 4
Vaccines 4
Liver and Kidney Disorders Drugs 4
Gastroenterology 4
Pharmaceutical Intermediates 3
Pulmonary Medicine 3
Colon Cancer Drugs 3
Proteomics 3
Drug Delivery 3
Laboratory Equipment 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Diabetes Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Cough and Cold Drugs 2
Medical Devices 2
Mental Disorders Drugs 2
Pancreatic Cancer Drugs 2
Kidney Cancer Drugs 2
Anti-Obesity Drugs 2
Pediatrics 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Laboratory Testing 1
Animal Healthcare/Veterinary 1
Diabetes Devices 1
Stem Cells 1
Blood Banking 1
Biomarkers 1
Hematology 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Cardiology 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

676 Results (Page 15 of 34)
- Relevance
  Sort by

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
820 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Red Biotechnology Market Report and Forecast 2024-2032

 Report
November 2023
172 Pages
Global

From

€2741EUR$2,799USD£2,279GBP

Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
48 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Cat Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
28 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
245 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report by Drug Class (Antihistamines, Epinephrine), Route Of Administration, Distribution Channel, Region, and Segment Forecasts, 2024-2030

 Report
December 2023
180 Pages
Global

From

€5826EUR$5,950USD£4,845GBP

Injectable Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

 Report
December 2023
492 Pages
Global

From

€3917EUR$4,000USD£3,257GBP

Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
207 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Cancer Biomarkers Market: Industry Trends and Global Forecasts 2024-2035: Distribution by Type of Biomarker, Type of Cancer and Key Geographical Regions

 Report
April 2024
309 Pages
Global

From

€4405EUR$4,499USD£3,664GBP

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
527 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
139 Pages
Global

From

€1958EUR$2,000USD£1,629GBP

Immuno-oncology Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

 Report
July 2022
100 Pages
Global

From

€2448EUR$2,500USD£2,036GBP

Collaboration Deals in Pharmaceuticals 2019-2024

 Report
September 2024
1150 Pages
Global

From

€3912EUR$3,995USD£3,253GBP

Ophthalmic Pharmaceutical Drugs - Global Strategic Business Report

 Report
November 2024
122 Pages
Global

From

€5336EUR$5,450USD£4,438GBP

Cervical Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
80 Pages
Global

From

€1714EUR$1,750USD£1,425GBP

€2448EUR$2,500USD£2,036GBP

Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target Disease Indication and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
September 2023
120 Pages
Global

From

€4699EUR$4,799USD£3,908GBP

Targeted Oncology Therapeutics: Lung Cancers

 Report
October 2021
82 Pages
Global

From

€3770EUR$3,850USD£3,135GBP

Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033

 Report
October 2023
284 Pages
Global

From

€4916EUR$5,196USD£3,950GBP

Ophthalmic Drugs Market Report 2024-2034

 Report
October 2023
284 Pages
Global

From

€5413EUR$5,722USD£4,350GBP

Melanoma Drug Market by Type, Product, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
195 Pages
Global

From

€3471EUR$3,545USD£2,887GBP

€3857EUR$3,939USD£3,208GBP

676 Results (Page 15 of 34)
- 1
- 13
- 14
- 15
- 16
- 17

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.